hj66705 Jul 2017 10:31
Looks like he/she may have known this was coming with his/her yesterday "I'm done posting here".
Two working days after the AGM and this saga takes a dramatic turn.
Having an AGM at 4pm on a Friday always sounded a tad iffy to me.
Just goes to show having a critical analysis approach to these companies rather than wearing rose tinted specs is highly advisable.
The AGM was to pass the resolutions as per the RNS above. A number of key things I took away:
1. The Readmission is waiting for compliance approval from AIM and in effect it is being treated as a new IPO, so Pathfinder doc, Long form, Short form, institutional presentations etc have to take place, because Mowana is now operational a new CPR report has to be completed, this has caused delays.
2. They have money in the bank to see through to readmission.
3. Once AIM sign off on the documents then a shareholder meeting will be called to agree the readmission, 14 days notice has to be given to shareholders.
4. Monies being raised on the readmission amount to no more than 3 months revenue from Mowana production.
5. Kossanto is progressing well and Randgold are looking at a much larger area to produce and updates will follow.
6. They are looking at a number of possible funding partners for Matala including the existing Chinese one.
They are very confident and pleased with the progress they are making, if anything they are frustrated with the red tape of AIM, which rightly so has to have everything verified based on the facts. There should be a serious upside rerate when this relists. Although they cannot make predictions a market Cap figure in the hundreds of millions was mentioned to me once the revenues they have already secured are recognised.